Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab.

被引：1
|
作者：
Georges, Sara
Shah, Parantu K.
Shapiro, Irina
Hicking, Christine
Lu, Lei
Hennessy, Meliessa
D'Angelo, Sandra P.
Cai, Ti
机构：
[1] EMD Serono Res & Dev Inc, Global Dev, Billerica, MA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.
    Badalamenti, Giuseppe
    Incorvaia, Lorena
    Algeri, Laura
    Carreca, Ignazio Ugo
    Brando, Chiara
    Madonia, Giorgio
    Peri, Marta
    Cucinella, Alessandra
    Perez, Alessandro
    Barraco, Nadia
    Russo, Tancredi Didier Bazan
    Pomi, Federica Li
    Carreca, Anna Paola
    Gristina, Valerio
    Galvano, Antonio
    Iovanna, Juan
    Fanale, Daniele
    Bazan, Viviana
    Russo, Antonio
    Carreca, Ignazio Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Augmentation of adoptive T-cell therapy for Merkel cell carcinoma with avelumab.
    Paulson, Kelly Garneski
    Perdicchio, Maurizio
    Kulikauskas, Rima
    Wagener, Felecia
    Church, Candice
    Bui, Kieu-Thu
    Vandeven, Natalie
    Thomas, Hannah
    McAfee, Megan
    Miller, Natalie
    Chin, Kevin M.
    Su, Zhen
    Greenberg, Philip D.
    Parvathaneni, Upendra
    Bhatia, Shailender
    Nghiem, Paul
    Chapuis, Aude
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Avelumab for the treatment of metastatic Merkel cell carcinoma
    Cordes, L. M.
    Gulley, J. L.
    DRUGS OF TODAY, 2017, 53 (07) : 377 - 383
  • [4] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Shirley, Matt
    TARGETED ONCOLOGY, 2018, 13 (03) : 409 - 416
  • [5] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Matt Shirley
    Targeted Oncology, 2018, 13 : 409 - 416
  • [6] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Tereza Lanitis
    Irina Proskorovsky
    Apoorva Ambavane
    Matthias Hunger
    Ying Zheng
    Murtuza Bharmal
    Hemant Phatak
    Advances in Therapy, 2019, 36 : 2327 - 2341
  • [7] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Lanitis, Tereza
    Proskorovsky, Irina
    Ambavane, Apoorva
    Hunger, Matthias
    Zheng, Ying
    Bharmal, Murtuza
    Phatak, Hemant
    ADVANCES IN THERAPY, 2019, 36 (09) : 2327 - 2341
  • [8] Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab.
    Bullement, Ash
    D'Angelo, Sandra P.
    Amin, Amerah
    Stapelkamp, Ceilidh
    Willis, Anna
    Lilley, Cameron
    Hatswell, Anthony
    Bharmal, Murtuza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
    Bullement, Ash
    Nathan, Paul
    Willis, Anna
    Amin, Amerah
    Lilley, Cameron
    Stapelkamp, Ceilidh
    Hatswell, Anthony
    Pescott, Chris
    Bharmal, Murtuza
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 377 - 390
  • [10] Prognosis for patients with metastatic Merkel cell carcinoma with a complete response on avelumab treatment
    Zijlker, L.
    Levy, S.
    Wolters, W.
    van Thienen, H. V.
    van Akkooi, A. C. J.
    Tesselaar, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S687 - S688
12345